يعرض 1 - 10 نتائج من 1,780 نتيجة بحث عن '"antigen presenting cell"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    المساهمون: Afd Pharmacology, Pharmacology, Biomedical International R+D GmbH, Austrian Science Fund, Bencard Allergie GmbH, Afify, Sheriene Moussa, Pacios, Luis F, Redegeld, Frank A, Pali-Schöll, Isabella, Hufnagl, Karin, Bianchini, Rodolfo, Guethoff, Sonja, Kramer, Matthias F, Fiocchi, Alessandro, Dvorak, Zdenek, Jensen-Jarolim, Erika, Roth-Walter, Franziska, Afify, Sheriene Moussa [0000-0003-2082-9038], Pacios, Luis F [0000-0002-0585-4289], Redegeld, Frank A [0000-0001-8830-7960], Pali-Schöll, Isabella [0000-0003-2089-6011], Hufnagl, Karin [0000-0002-2288-2468], Bianchini, Rodolfo [0000-0003-0351-6937], Guethoff, Sonja [0000-0001-5846-1035], Kramer, Matthias F [0000-0002-3740-4733], Fiocchi, Alessandro [0000-0002-2549-0523], Dvorak, Zdenek [0000-0002-3938-3585], Jensen-Jarolim, Erika [0000-0003-4019-5765], Roth-Walter, Franziska [0000-0001-5005-9228]

    المصدر: Clinical and Experimental Allergy, 52(3), 426. Blackwell Publishing Ltd
    Digital.CSIC. Repositorio Institucional del CSIC
    instname

    وصف الملف: application/pdf

  9. 9
  10. 10

    المصدر: Advanced Drug Delivery Reviews

    مصطلحات موضوعية: Vaccine delivery, SARS, Severe acute respiratory syndrome, TMPRSS2, Transmembrane protease serine 2, Alum, Aluminum hydroxide, APC, Antigen-presenting cell, Pharmaceutical Science, 02 engineering and technology, medicine.disease_cause, law.invention, Th1, aa, Amino acid, Clinical trials, law, Pandemic, CoV, Coronavirus, Coronavirus, 0303 health sciences, Public information, Clinical Trials as Topic, Vaccines, Synthetic, OWS, Operation Warp Speed, Vaccine production, RBM, Receptor binding motif, 021001 nanoscience & nanotechnology, Recombinant Proteins, HHS, US Department of Health and Human Services, Recombinant DNA, RSV, Respiratory syncytial virus, Health Resources, PTM, Post-translational modification, 0210 nano-technology, ADE, Antibody-dependent enhancement, Coronavirus Infections, 2019-20 coronavirus outbreak, COVID-19 Vaccines, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), RBD, Receptor binding domain, cGMP, Current good manufacturing practices, Neutralizing antibodies, Article, WHO, World Health Organization, Viral vector, 03 medical and health sciences, Drug Development, medicine, Animals, Humans, Adjuvants, NTD, N-terminal domain, Pandemics, 030304 developmental biology, SARS-CoV-2, MERS, Middle East respiratory syndrome, other, COVID-19, Viral Vaccines, S-protein, Spike protein (S1/S2), COVID, Coronavirus disease 2019, Virology, FDA, US Federal Drug Administration, Business, ACE-2, Angiotensin-converting enzyme 2, MNA, Micro-needle array

    وصف الملف: application/pdf